In vivo mitochondria‐targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy
The Journal of Physiology · 2024-03 · 602 (6) · 1211-1225
DOI: 10.1113/jp286178 ↗At a glance
Journal article in The Journal of Physiology, published online on 2024-02-21. Written by Zhongchao Wang and 12 co-authors. Institution: Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK. Major MEDLINE topics: Placenta, Uterine Artery. Cited 18 times so far (Crossref); 70 references. The full text is freely available (open access, CC BY 4.0). Funded by: British Heart Foundation.
Abstract (original language)
Gestational hypoxia adversely affects uterine artery function, increasing complications. However, an effective therapy remains unidentified. Here, we show in rodent uterine arteries that hypoxic pregnancy promotes hypertrophic remodelling, increases constrictor reactivity via protein kinase C signalling, and triggers compensatory dilatation via nitric oxide‐dependent mechanisms and stimulation of large conductance Ca 2+ ‐activated K + ‐channels. Maternal in vivo oral treatment with the mitochondria‐targeted antioxidant MitoQ in hypoxic pregnancy normalises uterine artery reactivity and prevents vascular remodelling. From days 6–20 of gestation (term ∼22 days), female Wistar rats were randomly assigned to normoxic or hypoxic (13–14% O 2 ) pregnancy ± daily maternal MitoQ treatment (500 µ m in drinking water). At 20 days of gestation, maternal, placental and fetal tissue was frozen to determine MitoQ uptake. The uterine arteries were harvested and, in one segment, constrictor and dilator reactivity was determined by wire myography. Another segment was fixed for unbiased stereological analysis of vessel morphology. Maternal administration of MitoQ in both normoxic and hypoxic pregnancy crossed the placenta and was present in all tissues analysed. Hypoxia increased uterine artery constrictor responses to norepinephrine, angiotensin II and the protein kinase C activator, phorbol 12,13‐dibutyrate. Hypoxia enhanced dilator reactivity to sodium nitroprusside, the large conductance Ca 2+ ‐activated K + ‐channel activator NS1619 and ACh via increased nitric oxide‐dependent mechanisms. Uterine arteries from hypoxic pregnancy showed increased wall thickness and MitoQ treatment in hypoxic pregnancy prevented all effects on uterine artery reactivity and remodelling. The data support mitochondria‐targeted therapy against adverse changes in uterine artery structure and function in high‐risk pregnancy. image Key points Dysfunction and remodelling of the uterine artery are strongly implicated in many pregnancy complications, including advanced maternal age, maternal hypertension of pregnancy, maternal obesity, gestational diabetes and pregnancy at high altitude. Such complications not only have immediate adverse effects on the growth of the fetus, but also they can also increase the risk of cardiovascular disease in the mother and offspring. Despite this, there is a significant unmet clinical need for therapeutics that treat uterine artery vascular dysfunction in adverse pregnancy. Here, we show in a rodent model of gestational hypoxia that in vivo oral treatment of the mitochondria‐targeted antioxidant MitoQ protects against uterine artery vascular dysfunction and remodelling, supporting the use of mitochondria‐targeted therapy against adverse changes in uterine artery structure and function in high‐risk pregnancy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
- Department of Aerospace Physiology, Fourth Military Medical University, Xi'an, China.
- Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China.
- The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia.
- Department of Surgical Sciences, University of Turin, Turin, Italy.
- Cambridge Cardiovascular Strategic Research Initiative, University of Cambridge, Cambridge, UK.
ORCID profiles: Emily J Camm, Alessandro Rolfo, Tullia Todros, Jin Ma, Youguo Niu, Dino A Giussani
Funding
- British Heart Foundation
Cite
APA
Wang, Z., Camm, E. J., Nuzzo, A. M., Spiroski, A. M., Skeffington, K. L., Ashmore, T. J., Rolfo, A., Todros, T., Logan, A., Ma, J., Murphy, M. P., Niu, Y., & Giussani, D. A. (2024). In vivo mitochondria‐targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy. The Journal of Physiology, 602(6), 1211-1225. https://doi.org/10.1113/jp286178
Vancouver
Wang Z, Camm EJ, Nuzzo AM, Spiroski AM, Skeffington KL, Ashmore TJ, et al. In vivo mitochondria‐targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy. The Journal of Physiology. 2024;602(6):1211-1225. doi:10.1113/jp286178
BibTeX
@article{Wang2024,
author = {Wang, Zhongchao and Camm, Emily J and Nuzzo, Anna Maria and Spiroski, Ana-Mishel and Skeffington, Katie L and Ashmore, Thomas J and Rolfo, Alessandro and Todros, Tullia and Logan, Angela and Ma, Jin and Murphy, Michael P and Niu, Youguo and Giussani, Dino A},
title = {In vivo mitochondria‐targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy},
journal = {The Journal of Physiology},
year = {2024},
volume = {602},
number = {6},
pages = {1211--1225},
doi = {10.1113/jp286178}
}
EUVIMED